Speaking Faculty
Aris Persidis, Ph.D.President, Biovista
Clare Thibodeaux, Ph.D.Vice President, Scientific Affairs, Cures Within Reach
Dr. Bruce BloomFounder, Cures Within Reach, Chief Collaboration Officer, Healx
Laura Kleiman, Ph.D.Founder & CEO, Reboot Rx
G. Sitta Sittampalam, Ph.D.Senior Advisor to the Director, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Christopher Lipinski, Ph.D.Scientific Advisor, Melior Discovery
Eyal Barash, JDFounder, Barash Law
James Doyle, Ph.D.Co-Founder and CEO, Modelis
Smith Heavner, Ph.D., RNScientific Director, CURE Drug Repurposing Collaboratory (CDRC), Critical Path Institute
Stephen CaseyFounder & CEO, The 505(b)(2) Platform
Michael DerbyManaging Partner, TardiMed Sciences
Heather Mortiboys, Ph.D.Professor of Cellular Neuroscience & Metabolism, University of Sheffield
David H. Crean, Ph.D., MBAManaging Director, Equitos Venture Partners
Malina Bakowski, Ph.D.Principal Investigator, Calibr at Scripps Research
Tomas Babak, Ph.D.Chief Executive Officer, Leapfrog Bio
Sven Jacobson, MBACEO, Woolsey Pharmaceuticals, Co-Founder & CEO, Martin Pharmaceuticals
Sundeep Dugar, Ph.D.President & Chief Executive Officer, Aayam Therapeutics
Yossef Av-Gay, Ph.D.Professor, Departments of Medicine and Microbiology and Immunology, University of British Columbia
Santiago Ramon-Garcia, Ph.D.ARAID Investigator, Research and Development Agency of Aragon (ARAID) Foundation
John SemanChief Executive Officer, Revitale Pharma
Yi Rang Kim, MD, Ph.D.Founder & CEO, ONCOCROSS
Martin de Kort, Ph.D.Senior Scientific Program Manager Translational Medicine & Drug Development, EATRIS
Jaykumar MenonChair and Co-founder, Open Source Pharma Foundation
Dr. Richard WyseDirector of Clinical Development, Cure Parkinson's